Literature DB >> 26802236

Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.

Atsunari Tsuchisaka1, Sanae Numata1, Kwesi Teye1, Yohei Natsuaki1, Tamihiro Kawakami2, Yoshito Takeda3, Wenqing Wang4, Kazushi Ishikawa4, Mizuki Goto4, Hiroshi Koga1, Ryosuke Sogame1, Norito Ishii1, Shinzo Takamori5, Tomoaki Hoshino6, Oliver Brandt7, Hendri H Pas8, Sakuhei Fujiwara4, Takashi Hashimoto9.   

Abstract

All plakin family proteins are known to be autoantigens in paraneoplastic pemphigus (PNP). In this study, we first examined whether PNP sera also react with epiplakin, another plakin protein, by various immunological methods using 48 Japanese PNP sera. Immunofluorescence confirmed that cultured keratinocytes expressed epiplakin. Epiplakin was detected by 72.9% of PNP sera by immunoprecipitation-immunoblotting with KU-8 cell extract, but not by immunoblotting of either normal human epidermal extract or KU-8 cell extract. Epiplakin was essentially not detected by 95 disease and normal control sera. Statistical analyses of various clinical and immunological findings revealed a significant correlation of the presence of anti-epiplakin antibodies with both bronchiolitis obliterans and mortality. No epiplakin-negative PNP case developed bronchiolitis obliterans. However, although 29.4% of European patients with PNP had bronchiolitis obliterans, significant correlation with anti-epiplakin autoantibodies was not observed. In further studies for lung, immunofluorescence showed the presence of epiplakin in normal human lung, particularly respiratory bronchiole, immunoprecipitation-immunoblotting showed that PNP sera reacted with epiplakin in cultured lung cells, and mice injected with polyclonal antibody specific to epiplakin histopathologically showed abnormal changes in small airway epithelia. These results indicated that epiplakin is one of the major PNP autoantigens and is related to PNP-related bronchiolitis obliterans.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26802236     DOI: 10.1038/JID.2015.408

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

Review 1.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

Review 2.  Bullous Diseases in Children: A Review of Clinical Features and Treatment Options.

Authors:  Brittney Schultz; Kristen Hook
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 3.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

4.  Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus.

Authors:  Tomohiro Kishi; Jun Nakata; Toshimasa Yamada; Shinichi Nakatsuka; Ai Matsuura; Masaru Shibano
Journal:  Ann Hematol       Date:  2021-03-22       Impact factor: 3.673

Review 5.  Paraneoplastic pemphigus: a short review.

Authors:  Marta Wieczorek; Annette Czernik
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-23

Review 6.  Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.

Authors:  Giovanni Paolino; Dario Didona; Giuseppe Magliulo; Giannicola Iannella; Biagio Didona; Santo Raffaele Mercuri; Elisa Moliterni; Michele Donati; Andrea Ciofalo; Guido Granata; Patricia Ranuzzi; Vincenzo Falasca; Stefano Calvieri
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

Review 7.  Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa.

Authors:  Jong Hoon Kim; Soo-Chan Kim
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 8.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 9.  Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm.

Authors:  Hanan Rashid; Aniek Lamberts; Gilles F H Diercks; Hendri H Pas; Joost M Meijer; Maria C Bolling; Barbara Horváth
Journal:  Am J Clin Dermatol       Date:  2019-12       Impact factor: 7.403

Review 10.  Diagnosis of Autoimmune Blistering Diseases.

Authors:  Mareike Witte; Detlef Zillikens; Enno Schmidt
Journal:  Front Med (Lausanne)       Date:  2018-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.